Further trials comparing aspirin with newer anticoagulants (dabigatran, apixaban and rivaroxaban ... in the production of this manuscript. Atrial fibrillation (AF) is the most common cardiac ...

The pharmacological advantages of rivaroxaban and the favorable results ... was utilized in the production of this manuscript. Atrial fibrillation (AF) is the most common cardiac arrhythmia ...

whether Afib patients with a low risk of stroke -- a group without an existing indication for anticoagulation -- were assigned lower-dose rivaroxaban (Xarelto) or placebo (7% vs 6.4%, HR 1.10 ...

Younger patients with the common heart rhythm disorder atrial fibrillation but no other risk ... (JNJ.N), opens new tab under the brand name Xarelto. The others received a placebo.

A recent study published in JAMA has raised concerns about the safety of certain blood pressure medications for patients with ...